IDEXX Laboratories, Inc.

Informe acción NasdaqGS:IDXX

Capitalización de mercado: US$40.7b

IDEXX Laboratories Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de IDEXX Laboratories de 9.9% y 8.3% por año respectivamente. Se prevé que el BPA crezca en un 10.4% al año. Se espera que la rentabilidad financiera sea de 40.1% en 3 años.

Información clave

9.9%

Tasa de crecimiento de los beneficios

10.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment16.2%
Tasa de crecimiento de los ingresos8.3%
Rentabilidad financiera futura40.1%
Cobertura de analistas

Good

Última actualización24 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet

Apr 11
IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet

IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)

Apr 08

Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jan 30
Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified

Jan 16

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

Jan 15
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit

Dec 31
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit

IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly

Dec 15
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly

Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Oct 26
Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

Oct 10
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Sep 07
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jul 04
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

May 31
These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

Apr 05
At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly

Feb 22
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly

Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Jan 05
Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Nov 24
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Sep 20
When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Outstanding Business, But Valuation Is Key

Aug 15

These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

Aug 15
These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

IDEXX Laboratories Stock Is Very Expensive

Aug 08

IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M

Aug 02

Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?

Jul 26
Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?

Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today

Jul 12
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today

Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jun 16
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Great Business, But Still Overvalued

May 25

We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

May 06
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$474 Based On Its Intrinsic Value?

Apr 23
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$474 Based On Its Intrinsic Value?

With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Apr 09
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Mar 07
Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories And Its Real Value

Feb 02

Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

Jan 06
Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

IDEXX: A Wonderful Business At An Unreasonably High Price

Nov 24

These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Safely

Oct 17
These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Safely

With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Oct 04
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:IDXX - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20264,8161,1781,0571,2209
12/31/20254,3921,0459651,09612
12/31/20243,9899288571,04112
12/31/20233,661845773907N/A
9/30/20233,588823680830N/A
6/30/20233,514791593747N/A
3/31/20233,431699456612N/A
12/31/20223,367679384543N/A
9/30/20223,340670438580N/A
6/30/20223,309664429578N/A
3/31/20223,274735605746N/A
12/31/20213,215745636756N/A
9/30/20213,135757663765N/A
6/30/20213,047728694770N/A
3/31/20212,858674666745N/A
12/31/20202,707582540648N/A
9/30/20202,591497445585N/A
6/30/20202,475460366524N/A
3/31/20202,457437286453N/A
12/31/20192,407428304459N/A
9/30/20192,351423290439N/A
6/30/20192,291407274418N/A
3/31/20192,252390262400N/A
12/31/20182,213377277400N/A
9/30/20182,170330280386N/A
6/30/20182,117307296386N/A
3/31/20182,045284300377N/A
12/31/20171,969263297373N/A
9/30/20171,906277N/A353N/A
6/30/20171,862263N/A343N/A
3/31/20171,820245N/A343N/A
12/31/20161,775222N/A339N/A
9/30/20161,732214N/A312N/A
6/30/20161,690202N/A289N/A
3/31/20161,637192N/A258N/A
12/31/20151,602192N/A222N/A
9/30/20151,554174N/A170N/A
6/30/20151,531182N/A186N/A
3/31/20151,508182N/A188N/A
12/31/20141,486182N/A236N/A
9/30/20141,488199N/A274N/A
6/30/20141,443193N/A259N/A
3/31/20141,405190N/A258N/A
12/31/20131,377188N/A246N/A
9/30/20131,343188N/A250N/A
6/30/20131,320185N/A246N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (9.9% al año) de IDXX es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (9.9% al año) de IDXX crezcan menos que el mercado US (14.6% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de IDXX crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (8.3% al año) de IDXX crezcan más rápidamente que los del mercado US (8% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 8.3% al año) de IDXX crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de IDXX sea muy elevada dentro de 3 años (40.1%).

Descubre empresas en crecimiento

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target